Pathological changes in mice with long term cuprizone administration. (June 2019)

• Record Type: Journal Article
• Authors: Nomura, Taichi; Bando, Yoshio; Nakazawa, Hitomi; Kanemoto, Soshi; Yoshida, Shigetaka
• Is Part Of: Neurochemistry international. Volume 126(2019)
• Page Start: 229
• Page End: 238
• Publication Date: 2019-06
• Subjects: Demyelination -- Cuprizone -- Parvalbumin -- Striatum -- Multiple sclerosis; Neurochemistry -- Periodicals; Neurochemistry -- Periodicals; Neurochimie -- Périodiques; Neurochemistry; Periodicals; 612.804205
• DOI: 10.1016/j.neuint.2019.03.018
• Languages: English
• ISSNs: 0197-0186

Abstract

Abstract: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). In MS, a long disease duration is known to be a strong risk factor for converting the clinical course of the disease from relapse remitting MS to secondary progressing MS. There is a hypothesis that long sustained demyelination may exhaust neurons, however, pathological changes induced in neurons following demyelination remain unknown. Cuprizone administration can induce and sustain demyelination in the mouse CNS. We examined pathological changes in mice following long sustained demyelination caused by up to 34-week cuprizone administration. Twelve-week cuprizone administration induced severe demyelination in the cerebral cortex, corpus callosum and deep cerebellar nuclei. Demyelination persisted up to 34 weeks, as shown by myelin basic protein immunohistochemistry. In contrast, cuprizone administration developed demyelination in the striatum by week 34. In these demyelinated regions, no neuronal loss was observed. However, in the striatum and deep cerebellar nuclei, cuprizone-induced demyelination changed the intracellular distribution of parvalbumin (PV). Furthermore, in the striatum, there was an increase in PV in the demyelinated axons and most PV immunoreactivity did not co-localize with SMI32 immunoreactivity in mice with 34-week cuprizone administration. Further, mice with 34-week cuprizone administration showed motor coordination dysfunction in the balance beam test. However, 12-week withdrawal from the cuprizone diet induced remyelination in the regions and motor coordination dysfunction recovered. These results indicate that 34-week cuprizone administration induces and sustains demyelination and results in reversible motor coordination dysfunction. The change of intracellular PV distribution suggests that PV may protect demyelinated axons by Ca 2+ buffering. This model may be useful to investigate pathological and behavioral changes following demyelination in the CNS. Highlights: Long term cuprizone administration induced reversible demyelination. No neuronal loss was induced by cuprizone administration. Intracellular parvalbumin distribution was changed in demyelinated regions. Parvalbumin was localized in demyelinated axons, but not damaged axons. Long term cuprizone administration induced reversible motor coordination dysfunction.